Published online before print September 13, 2001, doi: 10.1161/hh2101.098466
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on April 12, 2001
Revised on August 27, 2001
Accepted on August 29, 2001
Replacement of the Muscle-Specific Sarcoplasmic Reticulum Ca2+-ATPase Isoform SERCA2a by the Nonmuscle SERCA2b Homologue Causes Mild Concentric Hypertrophy and Impairs Contraction-Relaxation of the Heart
From the Laboratories of Physiology (M.V.H., P.V., F.W.) and Cardiology (G.A., K.S.) and the Center for Transgene Technology and Gene Therapy (S.H., M.D., D.C., P.C.), Flanders Interuniversity Institute for Biotechnology, KU Leuven, Belgium; GenomatixUSA (T.R.), Cincinnati, Ohio; Department of Physiology and Cell Biology (M.P.), Ohio State University College of Medicine and Health Sciences, Columbus, Ohio; and Département de Physiologie (B.A., J.L.), Université Catholique de Louvain, Brussels, Belgium.
* To whom correspondence should be addressed. E-mail: frank.wuytack{at}med.kuleuven.ac.be.
The cardiac sarco(endo)plasmic reticulum Ca2+-ATPase gene (ATP2A2) encodes the following two different protein isoforms: SERCA2a (muscle-specific) and SERCA2b (ubiquitous). We have investigated whether this isoform specificity is required for normal cardiac function. Gene targeting in mice successfully disrupted the splicing mechanism responsible for generating the SERCA2a isoform. Homozygous SERCA2a-/- mice displayed a complete loss of SERCA2a mRNA and protein resulting in a switch to the SERCA2b isoform. The expression of SERCA2b mRNA and protein in hearts of SERCA2a-/- mice corresponded to only 50% of wild-type SERCA2 levels. Cardiac phospholamban mRNA levels were unaltered in SERCA2a-/- mice, but total phospholamban protein levels increased 2-fold. The transgenic phenotype was characterized by a 
20% increase in embryonic and neonatal mortality (early phenotype), with histopathologic evidence of major cardiac malformations. Adult SERCA2a-/- animals (adult phenotype) showed a reduced spontaneous nocturnal activity and developed a mild compensatory concentric cardiac hypertrophy with impaired cardiac contractility and relaxation, but preserved ß-adrenergic response. Ca2+ uptake levels in SERCA2a-/- cardiac homogenates were reduced by 50%. In isolated cells, relaxation and Ca2+ removal by the SR were significantly reduced. Comparison of our data with those obtained in mice expressing similar cardiac levels of SERCA2a instead of SERCA2b indicate the importance of the muscle-specific SERCA2a isoform for normal cardiac development and for the cardiac contraction-relaxation cycle.
Key words: Ca2+-transporting ATPase • alternative splicing • gene targeting • cardiovascular abnormalities • cardiomegaly
This article has been cited by other articles:
 |
|
 |
|
  A. Van den Bergh, P. Vangheluwe, A. Vanderper, P. Carmeliet, F. Wuytack, S. Janssens, W. Flameng, P. Holvoet, and P. Herijgers Food-restriction in obese dyslipidaemic diabetic mice partially restores basal contractility but not contractile reserve Eur J Heart Fail, December 1, 2009; 11(12): 1118 - 1125. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Brini and E. Carafoli Calcium Pumps in Health and Disease Physiol Rev, October 1, 2009; 89(4): 1341 - 1378. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-K. Wu, C.-D. Tseng, Y.-T. Huang, C.-S. Hsieh, W.-S. Tsai, J.-L. Lin, F.-T. Chiang, and C.-T. Tsai Angiotensin II does not influence expression of sarcoplasmic reticulum Ca2 + ATPase in atrial myocytes Journal of Renin-Angiotensin-Aldosterone System, September 1, 2009; 10(3): 121 - 126. [Abstract] [PDF]
|
|
|
|
 |
|
 P. T. Caldwell, P. A. Thorne, P. D. Johnson, S. Boitano, R. B. Runyan, and O. Selmin Trichloroethylene Disrupts Cardiac Gene Expression and Calcium Homeostasis in Rat Myocytes Toxicol. Sci., July 1, 2008; 104(1): 135 - 143. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Van den Bergh, A. Vanderper, P. Vangheluwe, F. Desjardins, I. Nevelsteen, W. Verreth, F. Wuytack, P. Holvoet, W. Flameng, J.-L. Balligand, et al. Dyslipidaemia in type II diabetic mice does not aggravate contractile impairment but increases ventricular stiffness Cardiovasc Res, January 15, 2008; 77(2): 371 - 379. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Periasamy, P. Bhupathy, and G. J. Babu Regulation of sarcoplasmic reticulum Ca2+ ATPase pump expression and its relevance to cardiac muscle physiology and pathology Cardiovasc Res, January 15, 2008; 77(2): 265 - 273. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Moroy and F. Heyd The impact of alternative splicing in vivo: Mouse models show the way RNA, August 1, 2007; 13(8): 1155 - 1171. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. L. Stenoien, T. V. Knyushko, M. P. Londono, L. K. Opresko, M. U. Mayer, S. T. Brady, T. C. Squier, and D. J. Bigelow Cellular trafficking of phospholamban and formation of functional sarcoplasmic reticulum during myocyte differentiation Am J Physiol Cell Physiol, June 1, 2007; 292(6): C2084 - C2094. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. L. Boutz, G. Chawla, P. Stoilov, and D. L. Black MicroRNAs regulate the expression of the alternative splicing factor nPTB during muscle development Genes & Dev., January 1, 2007; 21(1): 71 - 84. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Nilius, G. Owsianik, T. Voets, and J. A. Peters Transient Receptor Potential Cation Channels in Disease Physiol Rev, January 1, 2007; 87(1): 165 - 217. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Lipskaia, F. del Monte, T. Capiod, S. Yacoubi, L. Hadri, M. Hours, R. J. Hajjar, and A.-M. Lompre Sarco/Endoplasmic Reticulum Ca2+-ATPase Gene Transfer Reduces Vascular Smooth Muscle Cell Proliferation and Neointima Formation in the Rat Circ. Res., September 2, 2005; 97(5): 488 - 495. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Kimura, M. Nakamori, J. D. Lueck, P. Pouliquin, F. Aoike, H. Fujimura, R. T. Dirksen, M. P. Takahashi, A. F. Dulhunty, and S. Sakoda Altered mRNA splicing of the skeletal muscle ryanodine receptor and sarcoplasmic/endoplasmic reticulum Ca2+-ATPase in myotonic dystrophy type 1 Hum. Mol. Genet., August 1, 2005; 14(15): 2189 - 2200. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Bobe, R. Bredoux, E. Corvazier, J. P. Andersen, J. D. Clausen, L. Dode, T. Kovacs, and J. Enouf Identification, Expression, Function, and Localization of a Novel (Sixth) Isoform of the Human Sarco/Endoplasmic Reticulum Ca2+ATPase 3 Gene J. Biol. Chem., June 4, 2004; 279(23): 24297 - 24306. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Brady, M. U Koban, K. A Dellow, M. Yacoub, K. R Boheler, and S. J Fuller Sp1 and Sp3 transcription factors are required for trans-activation of the human SERCA2 promoter in cardiomyocytes Cardiovasc Res, November 1, 2003; 60(2): 347 - 354. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Genetically Modified Animals in Endocrinology Endocr. Rev., June 1, 2003; 24(3): 388 - 388. [Full Text] [PDF]
|
|
|
|
|
|
G. Antoons, M. Ver Heyen, L. Raeymaekers, P. Vangheluwe, F. Wuytack, and K. R. Sipido Ca2+ Uptake by the Sarcoplasmic Reticulum in Ventricular Myocytes of the SERCA2b/b Mouse Is Impaired at Higher Ca2+ Loads Only Circ. Res., May 2, 2003; 92(8): 881 - 887. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. F Frank, B. Bolck, E. Erdmann, and R. H.G Schwinger Sarcoplasmic reticulum Ca2+-ATPase modulates cardiac contraction and relaxation Cardiovasc Res, January 1, 2003; 57(1): 20 - 27. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. R. Heinzel, V. Bito, P. G.A. Volders, G. Antoons, K. Mubagwa, and K. R. Sipido Spatial and Temporal Inhomogeneities During Ca2+ Release From the Sarcoplasmic Reticulum in Pig Ventricular Myocytes Circ. Res., November 29, 2002; 91(11): 1023 - 1030. [Abstract] [Full Text] [PDF]
|
|